These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1698654)

  • 1. Proteinase inhibitor alpha 1-antichymotrypsin has different expression in various forms of neuronal ceroid lipofuscinosis.
    Wisniewski KE; Kida E
    Exp Neurol; 1990 Oct; 110(1):121-6. PubMed ID: 1698654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered amyloid beta-protein precursor processing in brains of patients with neuronal ceroid lipofuscinosis.
    Wisniewski KE; Kida E; Gordon-Majszak W; Saitoh T
    Neurosci Lett; 1990 Nov; 120(1):94-6. PubMed ID: 2127306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topographic heterogeneity of amyloid B-protein epitopes in brains with various forms of neuronal ceroid lipofuscinoses suggesting defective processing of amyloid precursor protein.
    Wisniewski KE; Maslinska D; Kitaguchi T; Kim KS; Goebel HH; Haltia M
    Acta Neuropathol; 1990; 80(1):26-34. PubMed ID: 1694383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-protein immunoreactivity in brains of patients with neuronal ceroid lipofuscinosis: ultrastructural and biochemical demonstration.
    Kitaguchi T; Wisniewski KE; Maslinski S; Maslinska D; Wisniewski TM; Kim KS
    Neurosci Lett; 1990 May; 112(2-3):155-60. PubMed ID: 2193254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered protein patterns in brains of children with neuronal ceroid lipofuscinosis.
    Wisniewski KE; Gordon-Majszak W; Maslinski S; Heaney-Kieras J
    Am J Med Genet; 1992 Feb; 42(4):568-74. PubMed ID: 1376969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha 1-antichymotrypsin in brain aging and disease.
    Abraham CR; Potter H
    Prog Clin Biol Res; 1989; 317():1037-48. PubMed ID: 2513582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protease inhibitor, alpha 1-antichymotrypsin, is a component of the brain amyloid deposits in normal aging and Alzheimer's disease.
    Abraham CR; Potter H
    Ann Med; 1989; 21(2):77-81. PubMed ID: 2669847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha 1-antichymotrypsin is present together with the beta-protein in monkey brain amyloid deposits.
    Abraham CR; Selkoe DJ; Potter H; Price DL; Cork LC
    Neuroscience; 1989; 32(3):715-20. PubMed ID: 2689908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability in the clinical and pathological findings in the neuronal ceroid lipofuscinoses: review of data and observations.
    Wisneiwski KE; Kida E; Patxot OF; Connell F
    Am J Med Genet; 1992 Feb; 42(4):525-32. PubMed ID: 1319116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha 1-antichymotrypsin is present in diffuse senile plaques. A comparative study of beta-protein and alpha 1-antichymotrypsin immunostaining in the Alzheimer brain.
    Shoji M; Hirai S; Yamaguchi H; Harigaya Y; Ishiguro K; Matsubara E
    Am J Pathol; 1991 Jan; 138(1):247-57. PubMed ID: 1702930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha 1-antichymotrypsin is associated solely with amyloid deposits containing the beta-protein. Amyloid and cell localization of alpha 1-antichymotrypsin.
    Abraham CR; Shirahama T; Potter H
    Neurobiol Aging; 1990; 11(2):123-9. PubMed ID: 2190106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in neuropathology of the neuronal ceroid lipofuscinoses.
    Goebel HH; Schochet SS; Jaynes M; Brück W; Kohlschütter A; Hentati F
    Mol Genet Metab; 1999 Apr; 66(4):367-72. PubMed ID: 10191130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lectin histochemistry in brains with juvenile form of neuronal ceroid-lipofuscinosis (Batten disease).
    Wisniewski KE; Maslinska D
    Acta Neuropathol; 1990; 80(3):274-9. PubMed ID: 2399809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease.
    Abraham CR; Selkoe DJ; Potter H
    Cell; 1988 Feb; 52(4):487-501. PubMed ID: 3257719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease inhibitors as a model for NCL disease, with special emphasis on the infantile and adult forms.
    Ivy GO
    Am J Med Genet; 1992 Feb; 42(4):555-60. PubMed ID: 1376968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell biology and function of neuronal ceroid lipofuscinosis-related proteins.
    Kollmann K; Uusi-Rauva K; Scifo E; Tyynelä J; Jalanko A; Braulke T
    Biochim Biophys Acta; 2013 Nov; 1832(11):1866-81. PubMed ID: 23402926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative biology of the neuronal ceroid-lipofuscinoses (NCL): an overview.
    Jolly RD
    Am J Med Genet; 1995 Jun; 57(2):307-11. PubMed ID: 7668352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variant late infantile neuronal ceroid-lipofuscinosis: pathology and biochemistry.
    Tyynelä J; Suopanki J; Santavuori P; Baumann M; Haltia M
    J Neuropathol Exp Neurol; 1997 Apr; 56(4):369-75. PubMed ID: 9100667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for lipase abnormality: high levels of free and triacylglycerol forms of unsaturated fatty acids in neuronal ceroid-lipofuscinosis tissue.
    Banerjee P; Dasgupta A; Siakotos AN; Dawson G
    Am J Med Genet; 1992 Feb; 42(4):549-54. PubMed ID: 1609837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal processing of carboxy-terminal fragment of beta precursor protein (beta PP) in neuronal ceroid-lipofuscinosis (NCL) cases.
    Wisniewski KE; Gordon-Krajcer W; Kida E
    J Inherit Metab Dis; 1993; 16(2):312-6. PubMed ID: 8411989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.